|

[18F]FluorThanatrace Clinical Trials

3 actively recruiting trials across 1 location

Also known as: [18F]FTT

Pipeline

Phase 1: 2

Top Sponsors

  • Abramson Cancer Center at Penn Medicine3

Indications

  • Cancer3
  • Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer1
  • Neuroendocrine Carcinoma Metastatic1
  • Prostate Cancer Metastatic1
  • Pancreatic Tumors1

Philadelphia, Pennsylvania3 trials

FTT PET/CT in Metastatic Prostate Cancer

University of Pennsylvania Hospital

FTT PET/CT in Pancreatic Neuroendocrine Tumors

University of Pennsylvania, Perelman Center for Advanced Medicine

Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

Abramson Cancer Center of the University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.